Contributor/Getty Images
Scientists in California tested a way to coax certain fat cells to burn calories, rather than simply store energy. In new research involving mice, the team found it was possible to convert existing white fat cells into calorie-burning beige fat cells. The findings could pave the way to a new class of obesity…
Michael Siluk/UCG/Universal Images Group via Getty Images
Children and teens with high body mass index should be guided toward intensive lifestyle interventions to manage their weight, an influential panel of experts is recommending.
It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potential user wary: They don’t only help you lose weight—they supposedly…
Semaglutide, the active ingredient in popular diabetes and obesity drugs Ozempic and Wegovy, can also tweak people’s taste buds for the better, preliminary research suggests. Scientists found that women taking semaglutide improved their taste sensitivity, particularly to sweetness. The findings may illuminate another…
Results from the longest-running trial of semaglutide—the active ingredient in the popular drugs Ozempic and Wegovy—are in, and the verdict is decidedly positive. The study found that people taking semaglutide tended to maintain their initial weight loss for up to four years. Other trial data presented this week also…
The future of weight loss is looking more varied by the second. This week, scientists have reported the preliminary findings of a small trial testing out a novel, non-surgical procedure for obesity—one that works by burning part of the mucus-filled lining of the stomach. The patients in the trial lost about 8% of…
Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications.